Drugs / ethinyl estradiol/norelgestromin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00269620 | Jun 2005 → Dec 2006 | — | University of Pittsburgh | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ethinyl estradiol/norelgestromin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00269620 ↗ |
| Route | Other | “contraceptive patch worn for 7 days and replaced for use for 3 consecutive weeks followed by a one-week patch free interval” NCT00269620 ↗ |